BiotechTube
Home/DermBiont/Max N. Dawson
MN

Max N. Dawson

Chief Operating Officer

DermBiont

Therapeutic Areas

DermatologyHyperpigmentation Disorders

DermBiont Pipeline

DrugIndicationPhase
SM-030Melasma and other hyperpigmentation disorders of the skinUnknown

Leadership Team at DermBiont

KB
Karl Beutner, MD, PhD
Chief Executive Officer, Co-founder
N(
Nichola (Nick) Eliovits
Chief Financial Officer, Co-founder
ET
Emma Taylor, MD
Advisor, Dermatology
View full DermBiont profile